Soleno Therapeutics (SLNO)
(Delayed Data from NSDQ)
$45.12 USD
-4.11 (-8.35%)
Updated May 3, 2024 04:00 PM ET
After-Market: $45.06 -0.06 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
SLNO 45.12 -4.11(-8.35%)
Will SLNO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for SLNO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SLNO
Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why
Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going
SLNO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Could Help Soleno Therapeutics, Inc. (SLNO) Maintain Its Recent Price Strength
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Soleno (SLNO) Soars as Prader-Willi Syndrome Study Meets Goal
Other News for SLNO
Soleno Therapeutics 3M share Spot Secondary priced at $46.00
Soleno Therapeutics announces pricing of $138M public offering
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Soleno Therapeutics 2.5M share Spot Secondary; price range $45.00-$46.00